# Pharmacogenomics of Antidepressant Response in Children and Adolescents

> **NCT00516932** · — · COMPLETED · sponsor: **Duke University** · enrollment: 211 (actual)

## Conditions studied

- Anxiety Disorders
- Depression
- Eating Disorders
- Obsessive-Compulsive Disorder
- Suicide Prevention

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00516932
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 211 (ACTUAL)
- **Last updated:** 2015-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00516932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00516932, "Pharmacogenomics of Antidepressant Response in Children and Adolescents". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00516932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*